PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.18%
Both yoy net incomes decline, with CRK at -15.36%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
8.81%
Less D&A growth vs. CRK's 29.52%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
1521.43%
Some yoy growth while CRK is negative at -117.54%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
303.33%
SBC growth well above CRK's 5.81%. Michael Burry would flag major dilution risk vs. competitor’s approach.
175.97%
Slight usage while CRK is negative at -88.44%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-203.03%
AR is negative yoy while CRK is 69.84%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
181.48%
Some yoy usage while CRK is negative at -84.27%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
332.00%
Well above CRK's 13.10%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
63.76%
Some CFO growth while CRK is negative at -32.61%. John Neff would note a short-term liquidity lead over the competitor.
-13.98%
Negative yoy CapEx while CRK is 1.61%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
678.75%
Acquisition growth of 678.75% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
13.98%
Purchases growth of 13.98% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-41.67%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-13.98%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
152.73%
Investing outflow well above CRK's 4.83%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
12.50%
Debt repayment growth of 12.50% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.